All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Milan Milojevic, MD, PhD, MSCE, FESC
Ahmet Kilic, MD

Presentations

1. Case Presentation with Audience Polling
   Sameer Hirji, MD MPH
    
2. Landscape of HIT After Cardiac Surgery—Incidence and Outcomes
   Irsa Hasan, MD
    
3. Diagnosis of HIT After Cardiac Surgery—How Good is the 4T Score?
   Subhasis Chatterjee, MD
    
4. Venous Thromboembolism After Coronary Artery Bypass Increases Healthcare Costs: A Propensity Score Matched Analysis
   Alex M. Wisniewski, MD, MSc
    
5. When Should You Switch From Heparin, and What Is the Best Alternative?
   Natalie Roy, MD
    
6. Your Patient with HIT Needs Cardiac Surgery. Now What?
   Dave C. Fitzgerald, DHA, MPH, CCP
    
7. Interim Data Analysis-—Heparin vs. Bivalirudin and ECMO Oxygenator Performance
   Deep P. Vakil, MD
    
8. Debate: Heparin Is the Anticoagulant of Choice in the CTICU
   Osamudiamen Obanor, MD
    
9. Debate: Bivalirudin is the Anticoagulant of Choice in the CTICU
   Glenn Whitman, MD
   Disclosure(s): GWBN LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing)
    
10. Rebuttals
     
11. Panel Discussion